Staphylococcus Aureus Network Adaptive Platform Trial
University of Melbourne
8,000 participants
Feb 16, 2022
INTERVENTIONAL
Conditions
Summary
The Staphylococcus aureus Network Adaptive Platform (SNAP) trial is an International Multi-Centered Randomised Adaptive Platform Clinical Trial to evaluate a range of interventions to reduce mortality for patients with Staphylococcus Aureus bacteraemia (SAB).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Cefazolin
benzylpenicillin
Clindamycin
Vancomycin or Daptomycin
This involves testing a strategy rather than individual antibiotic agents
Whole body FDG PET/CT imaging will be performed using a standardised protocol describing patient preparation and minimum specifications for radiopharmaceutical production, quality control, and PET/CT acquisition.
Locations(161)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05137119